Foster Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
985
+35
+4% +$7.27K 0.01% 283
2026
Q1
$201K Buy
+950
New +$205K 0.01% 275
2024
Q3
Sell
-4,543
Closed -$447K 208
2024
Q2
$447K Buy
4,543
+11
+0.2% +$1.12K 0.02% 134
2024
Q1
$507K Buy
4,532
+34
+0.8% +$3.67K 0.03% 119
2023
Q4
$391K Hold
4,498
0.02% 123
2023
Q3
$391K Buy
4,498
+15
+0.3% +$1.36K 0.02% 123
2023
Q2
$424K Buy
4,483
+18
+0.4% +$1.52K 0.03% 119
2023
Q1
$337K Sell
4,465
-161
-3% -$12.1K 0.02% 124
2022
Q4
$356K Buy
4,626
+140
+3% +$10.6K 0.03% 113
2022
Q3
$299K Buy
4,486
+31
+0.7% +$1.97K 0.02% 114
2022
Q2
$233K Buy
4,455
+9
+0.2% +$512 0.02% 126
2022
Q1
$252K Hold
4,446
0.02% 120
2021
Q4
$229K Hold
4,446
0.02% 128
2021
Q3
$220K Hold
4,446
0.02% 134
2021
Q2
$254K Hold
4,446
0.03% 118
2021
Q1
$270K Hold
4,446
0.04% 109
2020
Q4
$239K Buy
+4,446
New +$231K 0.04% 97

Other funds holding CAH

Foster Group's CAH Position: Q2 2026 in Review

Foster Group increased its Cardinal Health (CAH) stake by 3.7% in Q2 2026, buying an estimated $7.27K and bringing the position to 985 shares worth $234K. The position accounts for 0.01% of the portfolio, ranked #283.

Foster Group first reported a position in CAH in Q4 2020 and has held it in 17 quarters since. The position peaked at $507K in Q1 2024. 218 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Foster Group held 985 shares of Cardinal Health worth $234K as of Q2 2026.
  • Foster Group bought 35 Cardinal Health shares in Q2 2026, an estimated $7.27K.
  • Cardinal Health made up 0.01% of Foster Group's portfolio in Q2 2026, its #283 holding.
  • Foster Group first reported a position in Cardinal Health in Q4 2020 and has held it in 17 quarters since.
  • Foster Group's Cardinal Health position peaked at $507K in Q1 2024.
  • 218 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.